Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Papillomavirus Infections 2Neuroblastoma 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Hemangiosarcoma 2HIV Infections 2Ependymoma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Anus Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thromboembolism 1Thrombocythemia, Essential 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Gemcitabine 18Cisplatin 14Paclitaxel 9Vinblastine 7Methotrexate 7Radiotherapy 6Doxorubicin 6Carboplatin 6Fluorouracil 4Surgical Procedures, Operative 3Mitomycin 3Filgrastim 3BCG Vaccine 3Gefitinib 2Docetaxel 2Cystectomy 2valrubicin 1rubitecan 1romidepsin 1piritrexim 1merphos 1lonafarnib 1durvalumab 1avelumab 1atezolizumab 1Watchful Waiting 1Urination 1Transurethral Resection of Bladder 1Taxes 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Urinary Bladder Neoplasms × Watchful Waiting × Clear all
NCT05148728 2021-12-08

Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors

Vall Hebron Insitut Recerca

Phase NA Unknown
120 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡